During the last several years, CARE Act services for people with HIV/AIDS has undergone tremendous amount of change due to the treatment advances for people living with HIV. These advances have decreased the number of reported AIDS cases and deaths in the US and improved the quality of life for people living with HIV/AIDS.
Since the late 1990s, the CARE Act has seen unprecedented growth in both primary care and ADAP. Future demand on resources is expected to escalate as the standard of care improves and as patients continue to respond to new drug therapies. The demand for these treatments has affected CARE Act services unevenly across the US. Some States have been able to respond to the increased demand; others have had severe difficulty balancing fiscal responsibility with client access due to increasing costs.
To describe the total number of primary care and ADAP services, client demographics, drugs dispensed, and funding and expenditures, data were collected from States and territories during 2000.
From 1999 to 2000, the percentage of ADAP and primary medical care services has been increased at about 15 to 20 percent respectively per year. Both Federal and State funding of primary care and ADAP has grown significantly over the past several years. State ADAPs have responded to the release of the Federal guidelines for the use of antiretrovirals by increasing spending on these pharmaceuticals from as little as 43 percent of all funds in earlier years to more than 90 percent of all funds in 2000.
Learning Objectives: N/A
Keywords: Ryan White, HIV/AIDS
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.